Low-dose lenalidomide maintenance after induction therapy in older patients with primary central nervous system lymphoma.

ABSTRACT:

SUBMITTER: Vu K 

PROVIDER: S-EPMC8776513 | biostudies-literature | 2019 Jul

REPOSITORIES: biostudies-literature